Analysis of Kawasaki disease showing elevated antibody titres of Yersinia pseudotuberculosis

Acta Paediatr. 2006 Dec;95(12):1661-4. doi: 10.1080/08035250600750080.

Abstract

Aim: To elucidate a clinical difference between patients with Kawasaki disease documented with Yersinia pseudotuberculosis infection and patients with Kawasaki disease without Yersinia pseudotuberculosis infection.

Patients and methods: From January 1985 to July 2004, 452 patients were diagnosed with Kawasaki disease. Forty-two patients had elevated antibody titres of Yersinia pseudotuberculosis and/or positive stool culture (Yersinia-positive group). Three hundred and thirty patients had no elevated antibody titres (Yersinia-negative group). We compared the clinical characteristics retrospectively.

Results: The age of onset in the Yersinia-positive group (3.05+/-2.20 y) was significantly higher than that in the Yersinia-negative group (2.31+/-2.05 y) (p=0.03). The age-adjusted statistical analysis demonstrated that the incidence of coronary artery lesions (dilatations plus aneurysms) in the Yersinia-positive group (22/42, 52.4%) was significantly higher than in the Yersinia-negative group (105/330, 31.8%) (p=0.001), and the incidence of additional administration of immunoglobulin in the Yersinia-positive group (13/36, 36.1%) was significantly higher than in the Yersinia-negative group (41/256, 16.0%) (p=0.004).

Conclusion: Our data suggest that Yersinia pseudotuberculosis infection might play a role in the developing mechanism of poor response to therapy and the tendency to develop coronary artery lesions in Kawasaki disease patients.

MeSH terms

  • Antibodies, Bacterial / isolation & purification*
  • Child, Preschool
  • Coronary Artery Disease / etiology
  • Diagnosis, Differential
  • Female
  • Humans
  • Immunoglobulins, Intravenous / therapeutic use
  • Infant
  • Male
  • Mucocutaneous Lymph Node Syndrome / diagnosis*
  • Mucocutaneous Lymph Node Syndrome / drug therapy
  • Mucocutaneous Lymph Node Syndrome / physiopathology
  • Retrospective Studies
  • Yersinia pseudotuberculosis / immunology*
  • Yersinia pseudotuberculosis / isolation & purification
  • Yersinia pseudotuberculosis Infections / complications
  • Yersinia pseudotuberculosis Infections / diagnosis*
  • Yersinia pseudotuberculosis Infections / drug therapy

Substances

  • Antibodies, Bacterial
  • Immunoglobulins, Intravenous